Job Description The position of a Business Unit Director (BUD) sits within the leadership team of the UK & RoI affiliate with key responsibilities of building, leading, and developing the Sobi cross-functional business unit. This is a hybrid role with the expectation of a minimum of 4 times a month in the office. The role will involve travel to expert centres and some international travel. Therapy Area: C3G C3 glomerulopathy (C3G) is a rare chronic kidney disease affecting one to two people per million each year. The name refers to the deposition of a very specific protein: the complement protein C3. It is currently thought that changes at the genetic level could play a role in the development of C3G. C3G is a new disease area for Sobi, and it will be critical to engage with nephrology experts and organisations to build partnerships and develop a broad understanding of the disease and its management. PNH PNH stands for paroxysmal nocturnal haemoglobinuria – an acquired, rare, chronic, potentially life-threatening blood disease commonly characterised by persistently low haemoglobin, thrombosis, and debilitating symptoms. It occurs when the cells in the bone marrow responsible for making red blood cells mutate and produce defective blood cells. Sobi has a strong presence in PNH in the UK and Europe and will launch in Ireland in 2025. Job Description: Lead the cross-functional Business Unit of sales and marketing, working in close synergy with Medical, Patient Access, Patient Engagement, and HQ TA functions to ensure one voice to all stakeholders. Take ownership of customer networking and manage ongoing key stakeholder relationships throughout the UK and Ireland. Develop and prepare C3G launch plans for the UK and Ireland, ensuring a clear focused link from strategy to execution aligned with the European/global team. Lead PNH business and expert interactions, supporting the Ireland Business Manager for a successful launch. Recommend optimal OPEX and FTE resources to build a successful C3G launch. Through partnership with the patient access team, collaborate and support to ensure optimal access/reimbursement in an area of high unmet need aligned with the global pricing strategy. Lead/participate in assigned HQ project groups and work in support of the Sobi global business plans. Provide a feedback loop for local market requirements and competitor activities to ensure they are fully reflected in the Sobi global strategic plan. Ensure ongoing completion of all required initial and ongoing training in local regulations and policies, and adherence to those regulations and policies for self and any direct reports. Accountability for the Business Unit P&L, including determining revenue forecasts to be delivered within an agreed OPEX cost base. Setting and ensuring delivery of key sales and marketing key performance indicators. Line Management: Recruit, train, develop, and lead marketing and sales teams with the goal of building a high-performing team. Line management of the Sales and Marketing personnel in the BU. Accountable for all recruitment, executed in a timely fashion to ensure the BU is suitably resourced to meet local business needs. Determine the appropriate structure of the BU, assess competencies and skill sets needed to ensure Sobi remains at the forefront of commercial excellence within this business area. Principal Interfaces/Relationships: Internal: Leadership of the BU, including Senior Brand Manager and National Account Manager, alongside future potential growth to include a Sales team. Cross-functional Global C3G team and local affiliate management and staff. Cross-functional Leadership across PACE and medical teams to ensure strategic and tactical alignment. External: Clinical treaters, nurses, biomedical scientists, pharmacists as needed, plus appropriate required relationships with agreed local market access stakeholders. Opinion leaders and decision-makers including local patient organisations.